Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
19 May 2025 at 10:12
Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and navigate other challenges